Dawn C. Buse, PhD
Advertisement
Articles by Dawn C. Buse, PhD
Reducing the frequency of migraine is only 1 step in the process of optimizing management and addressing the disease's impact on patients’ lives.
Advertisement
Latest Updated Articles
Patient Selection of Novel Therapies for Migraine TreatmentPublished: October 28th 2020 | Updated:
Unmet Needs in the Management of MigrainePublished: October 28th 2020 | Updated:
Behavioral and Lifestyle Strategies for Migraine ManagementPublished: October 28th 2020 | Updated:
Acute Treatment of Migraine: Traditional TherapiesPublished: October 28th 2020 | Updated:
Role of Neuromodulation for Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Evolution of Acute Treatment of MigrainePublished: October 28th 2020 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
BMB-101 Heads for Registrational Trials Following Positive Phase 2 Data in Absence Seizures, Developmental Encephalopathies
2
Key Neurology Trial Readouts to Watch in Early 2026
3
Phase 2 BREAKTHROUGH Data Released, Liriglutide Effective in Obesity-Related Migraine, FDA Approves Generic Glatiramer Acetate Injection
4
Oral Anticoagulants Do Not Raise ARIA Risk of Anti-Amyloid Alzheimer Therapies, Study Shows
5